Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IMCRNASDAQ:RUMNYSE:STM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIMCRImmunocore$30.10-1.2%$28.80$23.15▼$62.74$1.51B0.75434,375 shs127,223 shsRUMRumble$7.72-1.9%$7.99$4.92▼$17.40$3.35B0.73.07 million shs1.49 million shsSTMSTMicroelectronics$22.74-1.0%$22.90$17.25▼$45.39$20.42B1.565.52 million shs6.72 million shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIMCRImmunocore-0.46%+3.22%+3.01%-3.70%-47.56%RUMRumble-2.96%+4.10%+8.70%-35.49%+13.56%STMSTMicroelectronics-0.82%+10.31%+3.63%-7.28%-44.21%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIMCRImmunocore3.0394 of 5 stars4.21.00.00.03.04.20.0RUMRumble1.7141 of 5 stars3.31.00.00.01.32.50.6STMSTMicroelectronics4.2857 of 5 stars4.23.02.50.02.40.03.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIMCRImmunocore 2.45Hold$59.4497.49% UpsideRUMRumble 2.50Moderate Buy$14.0081.35% UpsideSTMSTMicroelectronics 2.36Hold$30.9736.20% UpsideCurrent Analyst Ratings BreakdownLatest IMCR, RUM, and STM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/25/2025STMSTMicroelectronicsDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy4/25/2025STMSTMicroelectronicsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold$18.00 ➝ $23.004/15/2025RUMRumbleWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetNeutral ➝ Neutral$8.004/14/2025IMCRImmunocoreJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$54.00 ➝ $50.004/10/2025IMCRImmunocoreNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$71.00 ➝ $71.004/7/2025IMCRImmunocoreMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$38.00 ➝ $33.003/26/2025RUMRumbleWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$13.00 ➝ $10.003/12/2025IMCRImmunocoreNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$71.00 ➝ $71.003/12/2025IMCRImmunocoreHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$100.00 ➝ $100.003/7/2025IMCRImmunocoreMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight$35.00 ➝ $35.002/28/2025IMCRImmunocoreHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$100.00 ➝ $100.00(Data available from 4/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIMCRImmunocore$310.20M4.86N/AN/A$7.42 per share4.06RUMRumble$95.49M35.11N/AN/A$0.65 per share11.88STMSTMicroelectronics$12.32B1.66$5.16 per share4.41$19.57 per share1.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIMCRImmunocore-$55.29M-$1.02N/AN/AN/A-15.87%-12.84%-5.09%5/6/2025 (Estimated)RUMRumble-$116.42M-$1.64N/AN/AN/A-152.81%-62.75%-50.56%5/13/2025 (Estimated)STMSTMicroelectronics$1.56B$1.1813.7012.161.1611.74%8.92%6.22%N/ALatest IMCR, RUM, and STM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025IMCRImmunocore-$0.35N/AN/AN/A$108.82 millionN/A5/13/2025Q1 2025RUMRumble-$0.11N/AN/AN/A$22.77 millionN/A4/24/2025Q1 2025STMSTMicroelectronics$0.05$0.07+$0.02$0.06$2.55 billion$2.52 billion3/25/2025Q4 2024RUMRumble-$0.13-$1.15-$1.02-$1.15$29.74 million$30.20 million1/30/2025Q4 2024STMSTMicroelectronics$0.35$0.37+$0.02$0.37$3.31 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIMCRImmunocoreN/AN/AN/AN/AN/ARUMRumbleN/AN/AN/AN/AN/ASTMSTMicroelectronics$0.301.32%+14.13%25.42%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIMCRImmunocore1.033.783.76RUMRumbleN/A3.943.94STMSTMicroelectronics0.113.112.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIMCRImmunocore84.50%RUMRumble26.15%STMSTMicroelectronics5.05%Insider OwnershipCompanyInsider OwnershipIMCRImmunocore10.40%RUMRumble70.10%STMSTMicroelectronicsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIMCRImmunocore32050.07 million45.48 millionOptionableRUMRumble70434.30 million116.54 millionOptionableSTMSTMicroelectronics48,300898.18 millionN/AOptionableIMCR, RUM, and STM HeadlinesRecent News About These CompaniesSTMicro rejects call to let shareholders vote on Italian board candidate, sources sayApril 30 at 12:34 PM | reuters.comSTMicroelectronics to cut 1,000 jobs in France, Italy talks ongoingApril 30 at 8:48 AM | reuters.comItaly seeks STMicro shareholder vote on rejected board candidate, sources sayApril 29 at 11:49 AM | reuters.comSTMicroelectronics NV: Navigating Revenue Challenges Amid Mixed Market SignalsApril 29 at 4:24 AM | tipranks.comSTMicroelectronics (NYSE:STM) Shares Sold by Mariner LLCApril 29 at 3:51 AM | marketbeat.comSTMicroelectronics Completes Share Buyback Program in April 2025April 28 at 5:12 PM | tipranks.comSTMicroelectronics (NYSE:STM) Price Target Raised to $23.00 at TD CowenApril 27 at 9:12 AM | marketbeat.comEnvestnet Asset Management Inc. Sells 189,206 Shares of STMicroelectronics (NYSE:STM)April 27 at 3:16 AM | marketbeat.comSTMicroelectronics: No 2025 Outlook And Depressed Earnings AheadApril 26, 2025 | seekingalpha.comSTMicroelectronics: No 2025 Outlook And Depressed Earnings AheadApril 26, 2025 | seekingalpha.comSTMicroelectronics (NYSE:STM) Shares Gap Up Following Strong EarningsApril 26, 2025 | americanbankingnews.comSTMicroelectronics price target lowered to EUR 25 from EUR 30 at BerenbergApril 25, 2025 | markets.businessinsider.comSTMicroelectronics price target raised to EUR 26 from EUR 24 at Deutsche BankApril 25, 2025 | markets.businessinsider.comSTMicroelectronics (STM) Price Target Raised by TD Cowen Analyst | STM Stock NewsApril 25, 2025 | gurufocus.comDeutsche Bank Increases Price Target for STMicroelectronics (STM) to EUR 26 | STM Stock NewsApril 25, 2025 | gurufocus.comTesla Supplier STMicroelectronics Expects Lower Sales, But Signals Recovery Is ComingApril 25, 2025 | wsj.comCautious Outlook for STMicroelectronics Amid Revenue Trough and Margin PressuresApril 25, 2025 | tipranks.comSTMicroelectronics Q1 Earnings Review: Bottoming Out, But Visibility Still Too LowApril 25, 2025 | seekingalpha.comMarshall Wace LLP Boosts Stock Holdings in STMicroelectronics (NYSE:STM)April 25, 2025 | marketbeat.comCautious Optimism Amid Uncertainties: Hold Rating Reflects Growth and ChallengesApril 24, 2025 | tipranks.comSTMicroelectronics: Hold Rating Amid Inventory Challenges and Capacity Expansion ConcernsApril 24, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesTime to Buy Alibaba and PDD After Tariff Exemptions?By Gabriel Osorio-Mazilli | April 17, 2025View Time to Buy Alibaba and PDD After Tariff Exemptions?Why Markets Suddenly See Opportunity in These Emerging MarketsBy Gabriel Osorio-Mazilli | April 9, 2025View Why Markets Suddenly See Opportunity in These Emerging MarketsBest Defense Stocks in 2025... So FarBy Chris Markoch | April 28, 2025View Best Defense Stocks in 2025... So FarCan NIO Overcome U.S.-China Tariff Headwinds?By Gabriel Osorio-Mazilli | April 8, 2025View Can NIO Overcome U.S.-China Tariff Headwinds?United States Steel's Crash: An Unmissable Buying OpportunityBy Gabriel Osorio-Mazilli | April 11, 2025View United States Steel's Crash: An Unmissable Buying OpportunityIMCR, RUM, and STM Company DescriptionsImmunocore NASDAQ:IMCR$30.10 -0.37 (-1.21%) As of 04:00 PM EasternImmunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 2/3 clinical trial to treat advanced cutaneous melanoma. In addition, the company's product pipeline comprises IMC-F106C, which is in a Phase 3 clinical trial to treat first line advanced cutaneous melanoma; and in a Phase 1/2 clinical trial in multiple tumor types, such as platinum resistant ovarian, non-small cell lung, and endometrial carcinoma. Further, it develops IMC-R117C, which is in phase 1 clinical trial to treat colorectal and gastrointestinal cancers; IMC-M113V, which is in phase 1 clinical trial to treat human immunosuppression virus; IMC-I109V, which is in a Phase I clinical trial in patients with chronic hepatitis B virus; IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-P115C, which is in preclinical trial to treat multiple solid tumor cancers; and IMC-S118AI to treat type 1 diabetes and is in preclinical trial. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.Rumble NASDAQ:RUM$7.72 -0.15 (-1.91%) As of 04:00 PM EasternRumble Inc. operates video sharing platforms in the United States, Canada, and internationally. The company operates rumble.com, a free-to-use video sharing and livestreaming platform where users can subscribe to channels to stay in touch with creators, and access video on-demand (VOD) and live content streamed by creators. It also operates locals.com, a platform where users can access free content and purchase subscriptions to support creators and access exclusive content in creator communities; Rumble Streaming Marketplace, a patent-pending application designed to enable a first-of-its-kind livestreaming and monetization service for creators; and Rumble Advertising Center (RAC), an online advertising management exchange. The company was founded in 2013 and is headquartered in Longboat Key, Florida.STMicroelectronics NYSE:STM$22.74 -0.24 (-1.04%) As of 03:59 PM EasternSTMicroelectronics N.V., together with its subsidiaries, designs, develops, manufactures, and sells semiconductor products in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates through Automotive and Discrete Group; Analog, MEMS and Sensors Group; and Microcontrollers and Digital ICs Group segments. The Automotive and Discrete Group segment offers automotive integrated circuits (ICs), and discrete and power transistor products. The Analog, MEMS and Sensors Group segment provides industrial application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs); general purpose analog products; custom analog ICs; wireless charging solutions; galvanic isolated gate drivers; low and high voltage amplifiers, comparators, and current-sense amplifiers; MasterGaN, a solution that integrates a silicon driver and GaN power transistors in a single package; wireline and wireless connectivity ICs; touch screen controllers; micro-electro-mechanical systems (MEMS) products, including sensors or actuators; and optical sensing solutions. The Microcontrollers and Digital ICs Group segment offers general purpose and secure microcontrollers; and radio frequency (RF) products. It also offers application-specific standard products for analog, digital and mixed-signal applications. In addition, the company provides assembly and other services. It sells its products through distributors and retailers, as well as through sales representatives. The company serves automotive, industrial, personal electronics and communications equipment, and computers and peripherals markets. STMicroelectronics N.V. was incorporated in 1987 and is headquartered in Geneva, Switzerland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
